XML 60 R49.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information (Details)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Sep. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
Sep. 30, 2025
USD ($)
segment
Sep. 30, 2024
USD ($)
Segment Reporting [Abstract]                
Number of reportable segments | segment             1  
Segment Reporting Information [Line Items]                
Interest income $ 697     $ 1,598     $ 2,544 $ 5,364
Interest expense (1,341)     (1,244)     (3,905) (3,389)
Loss on extinguishment of debt 0     0     0 (553)
Other income, net 0     97     179 1,709
Net loss (16,370) $ (17,982) $ (18,089) (16,673) $ (17,249) $ (16,193) (52,441) (50,115)
Reportable Segment                
Segment Reporting Information [Line Items]                
Collaboration revenue 0     0     0 1,885
Clinical development 5,802     4,162     15,841 12,574
General and administrative support 3,350     3,437     10,659 10,797
Research and discovery 3,692     4,125     10,548 11,670
Manufacturing 1,247     2,935     7,945 11,800
Other segment expenses 1,635     2,465     6,266 8,290
Interest income 697     1,598     2,544 5,364
Interest expense (1,341)     (1,244)     (3,905) (3,389)
Loss on extinguishment of debt 0     0     0 (553)
Other income, net 0     97     179 1,709
Net loss $ (16,370)     $ (16,673)     $ (52,441) $ (50,115)